PROSTASPY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

PROSTASPY Trademark

Serial Number: 79293978 • Registration: 6422408

PROSTASPY is a trademark filed by ABX advanced biochemical; compounds Biomedizinische; Forschungsreagenzien GmbH on July 15, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ABX advanced biochemical; compounds Biomedizinische; Forschungsreagenzien GmbH (7 trademarks)

Heinrich-Glaeser-Str. 10-14

Entity Type: 99

Trademark Details

Filing Date

July 15, 2020

Registration Date

July 20, 2021

Published for Opposition

May 4, 2021

Goods & Services

medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer; biological preparations for medical or pharmaceutical purposes for the treatment of cancer; preparations for use in medical diagnostic processes; preparations for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processes relating to the diagnosis of cancer

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2022 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Dec 10, 2021 NREP
GENERIC MADRID TRANSACTION SENT TO IB
Nov 23, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 22, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 20, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 20, 2021 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Jun 11, 2021 NREP
NOTIFICATION PROCESSED BY IB
May 11, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 4, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 4, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 19, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 14, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 13, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 24, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 24, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 5, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 4, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 28, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 22, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 17, 2020 REPR